As detailed above, CD8+ cytotoxic T cells, CD4+ effector T cells, and regulatory T cells each contribute uniquely to the immune dynamics in GBM, with their clinical relevance increasingly linked to their functional state and spatial distribution. This evidence concerns the gene CD4 and glioblastoma.